Please take a moment to review the important CME information on this page.

Migraine: Relieving The Pain
is no longer available for CME credit.

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Virginia School of Medicine and Public Health and Discovery Health Channel. The University of Virginia School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

The University of Virginia School of Medicine and Public Health designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Program Overview
Approximately 12% of U.S. adults suffer from migraine headache. Despite the availability of effective treatments, migraine often goes undiagnosed or is misdiagnosed. This CME program, Migraine: Relieving The Pain, will feature a panel of key opinion leaders to discuss migraine pathophysiology, diagnostic criteria, and new treatment options.

Learning Objectives
At the conclusion of this program, participants should be able to:

• Discuss the epidemiology of migraine.
• Discuss the socioeconomic effects and medical comorbidities associated with migraine.
• Review the diagnostic criteria of migraine.
• Explain current understanding of the pathophysiology of migraine, including the concept of central sensitization.
• Review pharmacologic approaches to acute migraine treatment.

Target Audience
Primary Care Physicians, Neurologists, Nurse Practitioners, Physician Assistants and other health care professionals.

Faculty Disclosure Information
As a sponsor accredited by the ACCME, it is the policy of the University of Virginia School of Medicine to require the disclosure of the existence of any significant financial interest or any other commercial supporter(s) of this activity or the manufacturer(s) of any commercial products(s) discussed in an educational presentation. Detailed disclosure will be made during the program.

Acknowledgement of Commercial Support
This program is funded by an educational grant from GlaxoSmithKline.